October 28, 2020
|Bolivian President Evo Morales invited members of the international press to join him at his mountain homeland in Bolivia, during the gathering in 2010. Here, he shared a traditional meal with us, fresh fish, purple potatoes and boiled corn on clay dishes, after Morales played a game of soccer. |
-- Brenda Norrell, Censored News
Democracy Now! reports: "In Bolivia, a court in La Paz has dismissed terrorism charges and annulled an arrest warrant against Evo Morales, arguing the former president’s rights and due process had been violated. The charges were issued following a right-wing coup last year that overthrew Morales. This comes as Morales has vowed to return to Bolivia after Luis Arce of Morales’s MAS party won last week’s presidential election by a landslide. Morales has been in exile for nearly one year."
October 26, 2020
|Nenahnezad, New Mexico Chapter House Today|
Throwing peanuts at Navajo elderly is demeaning
By Brenda Norrell
Pence's staff tests positive for coronavirus as Navajo Council and White House plan virus super spreader event for today, Tuesday, Oct. 27
Navajo elderly waiting in the cold today found out that the Navajo chapters only received 20 to 30 applications for hardship assistance. Some chapters received no applications, said Navajo family members as disabled elderly were being turned away.
The Navajo Nation had promised that today was the day for the elderly and disabled to apply for hardship relief of up to $1,500. It was the day for Dine' ages 65 and older, and disabled, to apply. But they were turned away in the cold due to the lack of applications.
While Navajo elderly were being turned away in the cold today -- the Navajo Council announced that a policy team from the White House will meet with the Navajo Council tomorrow, Tuesday. The public is not invited.
October 25, 2020
October 24, 2020
Unanswered Questions: Johns Hopkins fails to respond to vital questions -- 40 years of vaccine experiments on Navajos and Apaches
(2) Are blood and DNA of Navajo or Apache stored, how are they used and who has access to these?
For the past 40 years, Johns Hopkins Center for American Indian Health has worked in partnership with the Navajo Nation, White Mountain Apache Tribe, Indian Health Service and Tribal Health Organizations on studies aimed at reducing disease and improving the health and well-being of Native people. Past studies include three successful Phase 3 clinical trials of vaccines that are now used as part of routine immunizations that Native American children, as well as children across the US and the world receive as part of routine care: the Hib vaccine (against a leading cause of meningitis), the Prevnar vaccine (against a leading cause of pneumonia) and the rotavirus vaccine (against a leading cause of infectious diarrhea that can have severe effects in infants). All studies have been done by Native American and allied research personnel who are trained in the conduct of clinical trials, with the guidance of the communities and oversight of the Tribal IRBs.
Currently, the Johns Hopkins Center for American Indian Health is evaluating whether an investigational vaccine, created by Pfizer/BioNTech, is effective in preventing COVID-19 disease. There are no licensed vaccines against the virus that causes COVID-19 and finding safe and effective vaccines is critical to protecting families and ending the pandemic. The vaccine cannot give a person COVID-19 disease and there is no quarantine period required for those who enroll. Following consultation with health care providers, elders, and other community leaders, this study was submitted to the Navajo Nation Human Research Review Board (NNHRRB). The NNHRRB reviewed and approved this study, as did the Johns Hopkins Institutional Review Board. All individuals who seek to participate in the study receive extensive information on the trial through the informed consent process, and their participation is completely voluntary.
Additional details about study procedures and other details related to your questions are available on our website: https://caih.jhu.edu/news/pfizer-covid-19-vaccine-clinical-trial
Johns Hopkins Center for American Indian Health for Censored News
- Convalescent plasma study: This is a medical remedy that has been used for centuries and that could provide a critical stop-gap option for COVID-19 while we’re waiting for effective vaccines.
- Seroprevalence study: Serological data can provided critical evidence to guide policy and preparedness